12th ANNUAL BEER INSTITUTE BREWER'S BALL
PRESENTED BY matchboxfoodgroup AND ANHEUSER-BUSCH

More about D.C. Brewer's Ball and the CFF

 

Be part of the best nonprofit beer event in DC!

WHAT:  The 12th Annual Beer Institute Brewer’s Ball Presented by matchboxfoodgroup and Anheuser-Busch
has earned its reputation as the nonprofit beer and food event in DC, hosting over 35 of the region’s best craft breweries and 30 popular DC restaurants. Guests mix and mingle, while sampling handcrafted beers, tastes of the best local cuisine, and more. If the mood strikes, you can boogie on the dance floor featuring live entertainment, or bid on unique silent and live auction items and experiences. Take advantage of this annual tradition by inviting your family, friends, and clients to enjoy hand-crafted brews and signature samplings from the hottest eateries in DC. If there’s one thing we can guarantee – you won’t leave hungry or thirsty.

WHEN:
  Saturday, March, 5, 2016  - 7pm to Midnight

WHERE: National Building Museum, 401 F St NW, Washington D.C., 20001

ATTEND:
https://dcbrewersball.eventscff.org/site/participate.do?siteIdCode=R4S50BAT&tab=registration

DRESS CODE: Cocktail Attire

DONATE: Unable to attend but would like to make a donation? 
Please visit: 
https://dcbrewersball.eventscff.org/site/participate.do?siteIdCode=R4S50BAT&tab=donation


WHY:    Imagine struggling for every breath you take – something most people don’t have to think twice  about. For most, breathing is a voluntary act, the simple process of inhaling and exhaling to produce  oxygen in the brain. For those with cystic fibrosis (CF), this simple act is a daily battle.

The CF Foundation is the world’s leader in the  search for a cure for cystic fibrosis. We take great  pride in being one of the most efficient and effective organizations of our kind, and are careful stewards of  every dollar raised in support of our mission. Through  our venture philanthropy model, we are able to invest in promising CF research to develop a robust pipeline of  potential therapies that target the disease from every angle.

Recently, drug discovery and development programs have yielded drugs that have changed the course of cystic fibrosis. For the first time there are two FDA-approved therapies, Kalyedco and Orkambi, which treat not just the symptoms of the disease but the underlying genetic defect for a small percentage of the population.

We are optimistic about the road ahead, but it is a long one and the lives of people with CF are still cut far too short. The public’s support makes the difference in how we fulfill our mission to help people with CF live longer, healthier lives, while we search for a cure.

CONTACT:  For more information, please contact the Cystic Fibrosis Foundation Metropolitan Washington, D.C. Chapter at (301) 657-8444.

Sponsorship, Ticket Sales and Committee Participation - Erin Leahey (eleahey@cff.org)
Marketing & Tasting Stations - Jenna Vince (jswirskysacchetti@cff.org)
Auction - Elizabeth Farren (efarren@cff.org)